DDF launches $100 mln fund focused on treating dementia

By Iris Dorbian — 1 month ago

The Dementia Discovery Fund, which focuses on developing new dementia treatments, has raised $100 million. DDF’s backers include UK Government’s Department of Health, Alzheimer’s Research UK, Biogen, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Pfizer and Takeda. SV Life Sciences is managing the fund.


SRS Wants You to Play AcqMan for the Holidays

By Luisa Beltran — 3 years ago

Shareholder Representative Services is trying something new this holiday season. SRS is unveiling AcqMan — acq is short for acquisition–a game which tests players’ knowledge of M&A. This is how it works: Users pick from six different AcqMan avatars that represent different deep-pocketed strategic buyers. Choices include Dell, Google, IBM, Microsoft, Oracle and Takeda.